HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/
Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/, Blood, 82(10), 1993, pp. 10000166-10000166